NF-κB has been implicated in the pathogenesis of a variety of neurodegenerative diseases and A20, a key regulator of NF-kB activity, as well as additional A20-related proteases are likely to be involved in Alzheimer’s disease, Parkinson’s disease and stroke. Here, NFKB1 is linked to Stroke.